Oxytocin Add-on for Stable Depressed Patients

Summary

The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve depression symptoms in patients with Major Depressive Disorder (MDD) or Dysthymia Disorder.

Timeline

Start

2010-10

Primary completion

2015-02

Completion

2015-12

Outcome

Outcome not reported

Stopped (Business): “Break in funding”

Drugs

Indications